期刊文献+

鲍氏不动杆菌对亚胺培南耐药机制研究 被引量:16

Resistant Mechanism of Imipenem in Acinetobacter baumannii
在线阅读 下载PDF
导出
摘要 目的研究鲍氏不动杆菌对亚胺培南的耐药机制。方法检测62株鲍氏不动杆菌的耐药性,对其中对20株耐亚胺培南鲍氏不动杆菌进行耐药机制研究;检测ESBLs、AmpC酶、VIM、IMP、OXA-23和OXA-24产生及外膜蛋白表达情况,利血平协同抑制试验检测膜外排机制。结果鲍氏不动杆菌对亚胺培南耐药率为41%;对20株耐亚胺培南菌株中,ESBLs和AmpC酶阳性率分别50%和100%,VIMI、MP、OXA-24均阴性,OXA-23阳性率为95%;部分菌株存在22×103、29×103、33×103的外膜蛋白缺失;利血平不能降低亚胺培南对鲍氏不动杆菌的MIC值。结论产OXA-23型β-内酰胺酶是本院鲍氏不动杆菌对亚胺培南耐药的重要原因,产AmpC酶合并外膜蛋白缺失与耐亚胺培南鲍氏不动杆菌有密切关系。 OBJECTIVE To investigate the resistant mechanism of imipenem in Acinetobacter baumannii. METHODS Antimicrobial susceptibility was tested by agar dilution method, resistant mechanism was studied by 20 strains of imipenem-resistant A. baumannii. ESBLs, AmpC, VIM, IMP, OXA-23, OXA-24 and outermembrane protein were detected. Reserpine synergistic inhibition test was used to study the active efflux mechanism. RESULTS Among 62 A. baumannii strains, resistance to imipenem accounted for 41.0%; of the 20 imipenem-resistance strains, there were ESBLs positive in 50 %, AmpC in 100 % ; VIM, IMP, and OXA-24 were all negative; 95 % strains produced OXA-23; some resistant strains lacked the outermembrane protein with relative molecular mass about 22×10^3 , 29×10^3 and 33 ×10^3. The MICs of imipenem against A. baumannii couldn't be decreased by reserpine. CONCLUSIONS OXA-23 production is the important mechanism of imipenem resistance, AmpC production and lack in outermembrane protein are responsible for imipenem resigtance in A. baumannii.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2007年第4期375-378,共4页 Chinese Journal of Nosocomiology
基金 浙江省教育厅资助项目(SJY20041052)
关键词 鲍氏不动杆菌 亚胺培南 耐药性 机制 Acinetobacter baurnannii Imipenem Drug resistances Mechanism
  • 相关文献

参考文献4

二级参考文献22

  • 1褚少朋,邵海枫,李珍大,王卫萍,曹红琴.舒巴坦单剂对鲍曼不动杆菌的体外抑菌活性研究[J].临床检验杂志,2004,22(5):349-351. 被引量:19
  • 2张翊,卢建平.鲍氏不动杆菌感染及耐药性变化的趋势[J].中华医院感染学杂志,2004,14(3):341-343. 被引量:91
  • 3Bou G, Oliver A, Martinez-Beltran J. OXA-24, a novel class Dbeta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain [J].Antimicrob Agents Chemother, 2000,44(6):1556-1561.
  • 4Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC beta-lactamases among Escherichia coli,Klebsiella pneumoniae and Proteus mirabilis isolates at a veterans medical center [J]. J Clin Microbiol, 2000, 38(5):1791-1796.
  • 5Neuwirth C, Siebor E, Lopez J, et al. Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family enterobacteriaceae [J]. J Clin Microbiol,1996 34(1): 76-79.
  • 6Bou G, Martinez-Beltran J. Cloning ,nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii [J]. Antimicrob Agents Chemother,2000, 44(2): 428-432.
  • 7Livermore DM. Determinants of the activity of beta-lactamase inhibitor combinations [J]. J Antimicrob Chemother, 1993.31(Suppl A): 9-21.
  • 8Urban C, Go E, Mariano N, et al. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J Infect Dis, 1993, 167: 448-451.
  • 9Ang SW, Lee ST. Emergence of a multiply-resistant strain of Acinetobacter in a burns unit. Ann Acad Med Singapore, 1992, 21:660-663.
  • 10Manikal VM, Landman D, Saurina G, et al. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis, 2000, 31: 101-106.

共引文献128

同被引文献157

引证文献16

二级引证文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部